1.19

11.21% 0.12

Lexaria Bioscience Corp (LEXX)

Overview News Price History Financials Discussions Forecast Stock Split

Lexaria Bioscience Corp stock is traded at $1.19, with a volume of 350.50K. It is up +11.21% in the last 24 hours and up +42.77% over the past month. Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Previous Close:

$1.07

Open:

$1.09

24h Volume:

350.50K

Relative Volume:

2.08

Market Cap:

$23.28M

Revenue:

$411.00K

Net Income/Loss:

$-4.85M

P/E Ratio:

-2.7045

EPS:

-0.44

Net Cash Flow:

$-4.88M

1W Performance:

+15.53%

1M Performance:

+42.77%

6M Performance:

-17.36%

1Y Performance:

-66.19%

1-Day Range:

$1.06

$1.34

1-Week Range:

$0.97

$1.34

52-Week Range:

$0.7749

$3.565

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Name

Lexaria Bioscience Corp

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

250-765-6424

Address

100 - 740 MCCURDY ROAD, KELOWNA

Employee

Twitter

Next Earnings Date

2025-07-28

Latest SEC Filings

LEXX's Discussions on Twitter

Compare LEXX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LEXX Lexaria Bioscience Corp	1.19	19.75M	411.00K	-4.85M	-4.88M	-0.44
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Compare LEXX with other stocks

Lexaria Bioscience Corp Stock (LEXX) Latest News

Chart based analysis of Lexaria Bioscience Corp. trendsWeekly Earnings Recap & Low Volatility Stock Suggestions - Newser

Can Lexaria Bioscience Corp. Equity Warrant hit a new high this monthMarket Growth Summary & Real-Time Volume Trigger Notifications - Newser

Real time scanner hits for Lexaria Bioscience Corp. explained2025 AllTime Highs & Verified Chart Pattern Trade Signals - Newser

Multi asset correlation models including Lexaria Bioscience Corp.July 2025 EndofMonth & Reliable Price Action Trade Plans - Newser

Will Lexaria Bioscience Corp. Equity Warrant see short term momentumMarket Trend Review & Smart Swing Trading Alerts - Newser

Published on: 2025-09-12 17:52:14 - Newser

Identifying reversal signals in Lexaria Bioscience Corp. Equity Warrant2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser

Should you hold or exit Lexaria Bioscience Corp. nowJuly 2025 Breakouts & Long Hold Capital Preservation Plans - Newser

Using RSI to spot recovery in Lexaria Bioscience Corp.Earnings Miss & Free Reliable Trade Execution Plans - Newser

Published on: 2025-09-12 13:51:40 - Newser

Using AI based signals to follow Lexaria Bioscience Corp.Share Buyback & Free Reliable Trade Execution Plans - Newser

What institutional flow reveals about Lexaria Bioscience Corp. Equity Warrant2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser

Can momentum traders help lift Lexaria Bioscience Corp.Take Profit & Weekly High Potential Alerts - Newser

Is Lexaria Bioscience Corp. trending in predictive chart modelsJuly 2025 Gainers & Consistent Growth Equity Picks - Newser

Combining price and volume data for Lexaria Bioscience Corp.Risk Management & Expert Approved Momentum Trade Ideas - Newser

Can machine learning forecast Lexaria Bioscience Corp. recoveryBear Alert & Safe Capital Growth Tips - Newser

Analyzing Lexaria Bioscience Corp. Equity Warrant with multi timeframe chartsTrade Ideas & Fast Exit and Entry Strategy Plans - Newser

Will Lexaria Bioscience Corp. stock recover after recent dropJuly 2025 Fed Impact & Real-Time Market Trend Scan - Newser

Backtesting results for Lexaria Bioscience Corp. Equity Warrant trading strategiesQuarterly Trade Review & Capital Efficient Trading Techniques - Newser

Comparing Lexaria Bioscience Corp. in custom built stock radarsMarket Activity Report & Daily Oversold Bounce Ideas - Newser

Advanced analytics toolkit walkthrough for Lexaria Bioscience Corp. Equity WarrantLong Setup & Fast Gain Swing Trade Alerts - Newser

Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference - Investing News Network

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone - Investing News Network

Will Lexaria Bioscience Corp. Equity Warrant rebound enough to break evenWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser

Applying Elliott Wave Theory to Lexaria Bioscience Corp.2025 Earnings Impact & Accurate Intraday Trading Signals - Newser

What recovery options are there for Lexaria Bioscience Corp.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser

Real time scanner hits for Lexaria Bioscience Corp. Equity Warrant explained - Newser

Lexaria Bioscience Corp.’s volatility index tracking explainedQuarterly Profit Report & Real-Time Volume Analysis - Newser

Full technical analysis of Lexaria Bioscience Corp. stockEarnings Performance Report & Reliable Breakout Forecasts - Newser

Using R and stats models for Lexaria Bioscience Corp. Equity Warrant forecasting2025 Trading Volume Trends & Safe Entry Zone Tips - Newser

What Fibonacci levels say about Lexaria Bioscience Corp. rebound2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser

Is it time to cut losses on Lexaria Bioscience Corp.Market Growth Report & Stepwise Entry/Exit Trade Alerts - Newser

Combining price and volume data for Lexaria Bioscience Corp. Equity WarrantJuly 2025 Market Mood & Safe Entry Momentum Tips - Newser

What earnings revisions data tells us about Lexaria Bioscience Corp. Equity Warrant2025 Top Gainers & Reliable Volume Spike Alerts - Newser

Has Lexaria Bioscience Corp. Equity Warrant formed a bullish divergenceInsider Buying & Expert-Curated Trade Recommendations - Newser

Relative strength of Lexaria Bioscience Corp. Equity Warrant in sector analysisEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser

Using Bollinger Bands to evaluate Lexaria Bioscience Corp.Weekly Trend Report & Low Risk High Reward Trade Ideas - Newser

Is a relief rally coming for Lexaria Bioscience Corp. holdersJuly 2025 Analyst Calls & Weekly High Momentum Picks - Newser

Leading vs lagging indicators on Lexaria Bioscience Corp. performanceDip Buying & Intraday High Probability Setup Alerts - Newser

Will Lexaria Bioscience Corp. Equity Warrant outperform tech stocksPortfolio Performance Summary & Growth Oriented Trade Recommendations - Lancaster City Council

Is it too late to sell Lexaria Bioscience Corp.Weekly Risk Report & Stock Market Timing Techniques - Newser

Lexaria Bioscience Corp Stock (LEXX) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to LEXX